Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Chronic ACE and DPP4 Inhibition on Blood Pressure
NCT02130687Completed
- Sponsor
- Vanderbilt University
- Start
- Jun 2014
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of sitagliptin in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Vanderbilt University. Primary endpoints: Mean Arterial Blood Pressure, Heart Rate and 1 more. Started Jun 2014; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02130687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02130687.